Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EPITRON SUPER

K-Number: K834572 · 1984-04-23

Decision Date1984-04-23
Product CodeKCW
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

EPITRON SUPER is the device name listed in this FDA 510(k) record. The listed applicant is Leo Unlimited, Inc.. It received FDA 510(k) clearance on 1984-04-23 under 510(k) number K834572. The device is classified under product code KCW. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EPITRON SUPER?

EPITRON SUPER is a medical device that received FDA 510(k) clearance on 1984-04-23. The listed applicant is Leo Unlimited, Inc.. The 510(k) number is K834572.

When did EPITRON SUPER receive FDA 510(k) clearance?

EPITRON SUPER received FDA 510(k) clearance on 1984-04-23, under 510(k) number K834572.

Who is the listed applicant for EPITRON SUPER?

The FDA 510(k) record lists Leo Unlimited, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EPITRON SUPER?

The FDA product code for EPITRON SUPER is KCW.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Leo Unlimited, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: KCW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑